Imaging analysis of the in vivo bioreactor: A preliminary study

被引:9
作者
Holt, Ginger E. [1 ]
Halpern, Jennifer L. [1 ]
Lynch, Conor C. [1 ]
Devin, Clinton J. [1 ]
Schwartz, Herbert S. [1 ]
机构
[1] Vanderbilt Univ, Sch Med, Dept Orthopaed & Rehabil, Nashville, TN 37232 USA
关键词
D O I
10.1007/s11999-008-0295-3
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
The in vivo bioreactor is a hermetically sealed, acellular hydroxyapatite scaffold coated with growth factors that has a pulsating vascular pedicle leash threaded through its center. Tissue-engineered bone is created in weeks while the bioreactor remains embedded under the skin of an animal. The bioreactor also provides a model to study osteogenesis and pathologic scenarios such as tumor progression and metastasis by creating a controlled microenvironment that makes skeletogenesis amenable to genetic and physical manipulation. Animal euthanasia is required to quantitate bioreactor osteogenesis through histomorphometry. Nondestructive measures of new bone growth within the bioreactor are critical to future applications and are the primary questions posed in this study. We compared microcomputed tomography and micro-MRI assessments of bioreactor osteogenesis with conventional histomorphometric measurements in 24 bioreactors and asked if new bone formation could be calculated while the animal was alive. Microcomputed tomography visually, but not numerically, differentiated engineered new bone on its coral scaffold. Dynamic contrast-enhanced micro-MRI demonstrated augmented vascular flow through the bioreactor. Three-dimensional imaging can nondestructively detect tissue-engineered osteogenesis within the implanted bioreactor in vivo, furthering the usefulness of this unique model system.
引用
收藏
页码:1890 / 1896
页数:7
相关论文
共 14 条
[1]   Bone morphogenetic proteins [J].
Chen, D ;
Zhao, M ;
Mundy, GR .
GROWTH FACTORS, 2004, 22 (04) :233-241
[2]   Magnetic resonance imaging measurements of the response of murine and human tumors to the vascular-targeting agent ZD6126 [J].
Evelhoch, JL ;
LoRusso, PM ;
He, ZQ ;
DelProposto, Z ;
Polin, L ;
Corbett, TH ;
Langmuir, P ;
Wheeler, C ;
Stone, A ;
Leadbetter, J ;
Ryan, AJ ;
Blakey, DC ;
Waterton, JC .
CLINICAL CANCER RESEARCH, 2004, 10 (11) :3650-3657
[3]   The prefabrication of a bone graft in a rat model [J].
Gill, DRJ ;
Ireland, DCR ;
Hurley, JV ;
Morrison, WA .
JOURNAL OF HAND SURGERY-AMERICAN VOLUME, 1998, 23A (02) :312-321
[4]   Synthesis and in vitro biocompatibility of injectable polyurethane foam scaffolds [J].
Guelcher, SA ;
Patel, V ;
Gallagher, KM ;
Connolly, S ;
Didier, JE ;
Doctor, JS ;
Hollinger, JO .
TISSUE ENGINEERING, 2006, 12 (05) :1247-1259
[5]   The application of a murine bone bioreactor as a model of tumor: bone interaction [J].
Halpern, Jennifer ;
Lynch, Conor C. ;
Fleming, Jonathan ;
Hamming, David ;
Martin, Michelle D. ;
Schwartz, Herbert S. ;
Matrisian, Lynn M. ;
Holt, Ginger E. .
CLINICAL & EXPERIMENTAL METASTASIS, 2006, 23 (7-8) :345-356
[6]   Evolution of an in vivo bioreactor [J].
Holt, GE ;
Halpern, JL ;
Dovan, TT ;
Hamming, D ;
Schwartz, HS .
JOURNAL OF ORTHOPAEDIC RESEARCH, 2005, 23 (04) :916-923
[7]   Osteoclast differentiation in ectopic bone formation induced by recombinant human bone morphogenetic protein 2 (rhBMP-2) [J].
Irie, K ;
Alpaslan, C ;
Takahashi, K ;
Kondo, Y ;
Izumi, N ;
Sakakura, Y ;
Tsuruga, E ;
Nakajima, T ;
Ejiri, S ;
Ozawa, H ;
Yajima, T .
JOURNAL OF BONE AND MINERAL METABOLISM, 2003, 21 (06) :363-369
[8]  
JARCHO M, 1981, CLIN ORTHOP RELAT R, P259
[9]   Self-regenerating bone implant: Ectopic osteoinduction following intramuscular implantation of a combination of rhBMP-2 atelopeptide Type I collagen and porous hydroxyapatite [J].
Kusumoto, K ;
Bessho, K ;
Fujimura, K ;
Konishi, Y ;
Ogawa, Y ;
Iizuka, T .
JOURNAL OF CRANIO-MAXILLOFACIAL SURGERY, 1996, 24 (06) :360-365
[10]   FABRICATION OF VASCULARIZED BONE-GRAFTS USING CERAMIC CHAMBERS [J].
MIZUMOTO, S ;
INADA, Y ;
WEILAND, AJ .
JOURNAL OF RECONSTRUCTIVE MICROSURGERY, 1993, 9 (06) :441-449